Perioperative Management of Medical Comorbidities After Bariatric Surgery

With evolution, we have moved away from the concept of ‘bariatric surgery’ towards the present concept of ‘metabolic surgery’ where we look beyond just weight loss [1]. Recent evidences from literature clearly shows that the surgical remission of type 2 diabetes mellitus (T2DM) is now possible in the long term without the need for medications [2, 3]. It has also been shown that the reduction in medications post bariatric surgery has a significant economic benefit with reduction of medication costs required for the treatment of diabetes, hypertension and dyslipidemia [4]. This surgical concept of treatment of diabetes has been endorsed by many diabetic associations including the International Diabetic Federation [5].